These observations from the c-MYC tumor model were later validated in a study by Viale et al. [133] in a mutant KRAS-dependent cancer model, and this team reported a potential role for mitochondria in cancer cell survival following the downregulation of mutant KRAS. Here, KRAS is linked to neoplasm.